Recent trading context for Covista (CVSA)
Covista (CVSA) has drawn investor attention after recent trading, with the stock last closing at US$122.93. The company operates in the healthcare education space, with operations across the United States and the Caribbean.
See our latest analysis for Covista.
While Covista’s share price is down 2.83% over the last day and 8.08% over the week, the 90 day share price return of 28.70% and 3 year total shareholder return of 182.60% point to longer term momentum that has so far outweighed the 8.77% decline in 1 year total shareholder return.
If you are comparing Covista with other opportunities in the sector, this is a good time to broaden your search and check out a solid balance sheet and fundamentals stocks screener, including solid balance sheet and fundamentals stocks screener (45 results)
With Covista trading at US$122.93 alongside revenue of US$1.91b and net income of US$249.68m, plus an implied discount to some valuation estimates, investors may ask whether there is a buying opportunity here or whether the market is already pricing in future growth.
Most Popular Narrative: 19.8% Undervalued
Covista’s most followed narrative puts fair value at $153.25, which sits well above the last close of $122.93 and presents a clearly optimistic case.
Persistent health care workforce shortages in nursing, medicine and behavioral health create a structural need for large scale training capacity, which can support sustained demand for Covista's programs and underpin revenue growth.
Curious what earnings power this scenario is built on? Revenue, margins and future valuation multiples all play a role in this model. The specific mix might surprise you.
Result: Fair Value of $153.25 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, you also need to weigh risks, such as weaker enrollment trends at Chamberlain or tighter student lending rules making programs less affordable and putting pressure on growth.
Find out about the key risks to this Covista narrative.
Next Steps
With the narrative leaning optimistic, it helps to move fast, review the numbers in detail and test whether they match your expectations. To see what is driving that optimism, take a closer look at the 4 key rewards.
Looking for more investment ideas?
If you stop with just one stock, you could miss opportunities that fit your goals even better, so take a few minutes to compare what else is out there.
- Spot fresh opportunities with strong finances by reviewing companies in the solid balance sheet and fundamentals stocks screener (45 results).
- Target potential value by scanning the 50 high quality undervalued stocks that currently meet strict quality criteria.
- Strengthen your income focus by checking out the 12 dividend fortresses that combine yield with resilience.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com